The University of Cambridge is a partner in the €1 billion Quantum Flagship, an EU-funded initiative to develop quantum technologies across Europe.
Europe's Graphene Flagship lays out a science and technology roadmap, targeting research areas designed to take graphene and related two-dimensional materials from academic laboratories into society.
Eve, an artificially-intelligent ‘robot scientist’ could make drug discovery faster and much cheaper, say researchers writing in the Royal Society journal Interface. The team has demonstrated the success of the approach as Eve discovered that a compound shown to have anti-cancer properties might also be used in the fight against malaria.
A major research initiative which will create a European network of academics and companies working on graphene has been approved, with the University of Cambridge set to take a leading role.